Clinical Trial Update: Liposomal Bupivacaine in Rotator Cuff Repair [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating liposomal bupivacaine for pain control after rotator cuff repair has completed. Results were posted in May 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotator Cuff Injury

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Rotator Cuff Injury | Phase 4 | Status: COMPLETED | Results posted: 2024-05-16